Three stacking concerns in a leave-on brightening serum intended for reactive, PIH-prone skin. First, Alcohol Denat appears at a meaningful concentration in the formula (not the primary ingredient but well up in the list) and is a documented barrier disruptor with daily leave-on use on compromised skin. Second, Lavandula Angustifolia Oil and its declared allergen Linalool introduce a fragrance sensitisation risk. Fragrance allergy is the most common cause of contact reactions, and a brightening serum typically sits on already-reactive skin for extended periods. Third, Citrus Aurantium Tachibana Peel Extract contains furanocoumarins with phototoxic potential, making UV sensitisation a genuine concern in a product typically applied in the morning. Propylene Glycol appearing high in the formula acts as a penetration enhancer, which may amplify delivery of all active ingredients including the sensitising ones.

The brightening active, 3-O-Ethyl Ascorbic Acid, is a stable Vitamin C ether derivative with good published evidence for brightening and antioxidant activity. It appears at a plausible position in the formula, though its exact concentration is not publicly disclosed. Hydroxypropyl Tetrahydropyrantriol contributes hydration and Adenosine adds a soothing benefit. The combination of Alcohol Denat as a delivery vehicle and Salicylic Acid at a mid-formula position increases the irritation-stacking risk for daily use. pH data is not publicly available, which limits independent assessment of the formula's pH-dependent performance and comfort profile.

The full ingredient list is published and Linalool is declared as required under EU regulation. Active concentrations for the brightening derivative are not disclosed. The 'Clearly Corrective' branding implies a clean, corrective formula, but the presence of Alcohol Denat, Lavender Oil, and a phototoxic citrus extract is not acknowledged anywhere in product communications. The phototoxic risk of the citrus extract is particularly relevant given that this serum is typically marketed and used as a morning brightening product. No published clinical study for the finished product's brightening efficacy is accessible.

Kiehl's states 'dermatologist tested' but does not publish a study with lab name, method, or result for this product. No published clinical brightening study, no patch test report, and no phototoxicity assessment is publicly accessible for the finished product. The full INCI is on kiehls.com. This is a Grade C profile: the brand implies testing has occurred but supporting documentation is not publicly visible.

Application instructions are available on the brand page. There is no prominent guidance about the phototoxic potential of the citrus extract in a morning product, no specific warning about the Alcohol Denat-Lavender Oil combination for reactive or sensitised skin, and no patch test recommendation prominent in the product communications.